Lyn Baranowski - 10 Nov 2021 Form 4 Insider Report for Rani Therapeutics Holdings, Inc. (RANI)

Role
Director
Signature
/s/ Josh Seidenfeld, Attorney-in-Fact for Lyn Baranowski
Issuer symbol
RANI
Transactions as of
10 Nov 2021
Net transactions value
$0
Form type
4
Filing time
12 Nov 2021, 17:32:32 UTC
Next filing
27 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RANI Stock Option (Right to Buy) Award $0 +31,695 $0.000000 31,695 10 Nov 2021 Class A Common Stock 31,695 $26.78 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option vest as follows: 1/3rd of the shares subject to the option vest on November 10, 2022; and 1/36th of the shares subject to the option vest monthly thereafter over the following two years.